Tiny, Motorized Pill Delivers Vaccine to Mouse Intestine

The pea-size machine uses body fluids as fuel to propel itself through the digestive tract.

Written byEmma Yasinski
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

A new type of vaccine vehicle—this one literally has a teeny tiny motor—can drive itself to the mucosal linings of mouse intestines, potentially allowing for broader protection against infection, according to a study last week in Nano Letters.

Nanoengineers Liangfang Zhang and Joseph Wang at the University of California, San Diego, teamed up to design an ingestible device that can navigate the digestive system of rodents, stick itself to the mucosal lining of the gut, and deliver its payload. Aside from obviating the need for shots, the team says, the motorized vaccine may have another crucial benefit: its ability to build mucosal immunity.

Mucosal immunity is our body’s “first line of defense,” says David Lo, a biomedical scientist at the University of California, Riverside, who has studied vaccines and mucosal immunity. “Yet, there are almost no vaccines that we have on the market that actually try to induce this kind ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • emma yasinski

    Emma is a Florida-based freelance journalist and regular contributor for The Scientist. A graduate of Boston University’s Science and Medical Journalism Master’s Degree program, Emma has been covering microbiology, molecular biology, neuroscience, health, and anything else that makes her wonder since 2016. She studied neuroscience in college, but even before causing a few mishaps and explosions in the chemistry lab, she knew she preferred a career in scientific reporting to one in scientific research.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies